###### Strengths and limitations of this study

-   Addresses falls prevention intervention in an often excluded population, older people with visual impairment, with a known efficacious falls prevention intervention (Falls Management Exercise---FaME).

-   Working with older people with visual impairment to adapt FaME to their needs, a programme so far only tested on sighted people.

-   As a feasibility study run in two study sites, it does not have the power to show effectiveness but will allow informed planning for a definitive randomised controlled trial in the future if shown to be feasible.

Background {#s1}
==========

One in eight people in the UK aged over 75 and one in three aged over 90, live with significant sight loss.[@R1] Visually impaired older people (VIOP) are more likely to move into residential settings than sighted peers, be physically dependent and have poorer quality of life.[@R2] Vision impairment (VI) is associated with a loss of function in activities of daily living.[@R5] [@R6] A UK report by Visibility[@R7] found that older people are highly likely to avoid activity because of their VI. Anxiety and depression are also common in those with VI and this also leads to reduced activity.[@R8]

Falls are seldom due to a single cause.[@R9] [@R10] Poor vision has been identified as being particularly related to the recurrence of falls[@R11] although VI is not independently associated with higher incidence of falls.[@R12] Visual acuity, contrast sensitivity and visual field defects have been identified as important features of poor vision and VI related to falls risk.[@R13] [@R14] VIOP have a 1.7 times higher risk of falling than the general population and report more contact with their general practitioner (GP) and more hospital and nursing home admissions than their peers who do not have VI.[@R14] [@R15] Estimates of the number of falls attributed to VI suggest that 8% of falls-related hospital admissions are likely to occur in visually impaired people, accounting for 21% of the total cost of treating accidental falls.[@R15] These estimates may hide wide geographical variation and falls attributed to VI are underestimated, as reasons for falling may not be known or recorded and costs to GPs may not be included in treatment costs.[@R15]

Falls in older people cost the National Health Service (NHS) ∼4.6 million per day.[@R16] Evidence suggests multifactorial falls intervention programmes are effective in reducing falls among older people and include tackling underlying health problems, initiating strength and balance training, offering home modifications and checking footwear.[@R17] [@R18] One study has considered both occupational therapy and physiotherapy intervention in people with visual impairment and saw a reduction in falls.[@R19] In the UK, the National Service Framework for Older People[@R20] suggested that falls should be addressed in NHS. In 2004, the National Institute for Health and Care Excellence (NICE) guidelines on prevention and assessment of falls in older people[@R21] suggested that by 2005, all NHS boards in the UK should provide a falls service. A survey in 2008[@R22] highlighted that just half of participating falls clinics in the UK, assessed for VI but there was little information about how to modify falls prevention programmes for VIOP.

Fear of falling (FoF), with or without a fall, is also common in VIOP and can lead to a cycle of restricting daily activity and mobility with loss of confidence, diminishing physical and mental assets, reduced social participation and overall quality of life.[@R23] FoF is a broad term encompassing fear, anxiety, impaired perception of ability to walk safely without falling and loss of confidence.[@R26] FoF is a significant predictor of a future fall.[@R27] It is clear, in therapists and participants, that there is a distinction between proper caution around activity and an overcautious/fear-avoidance cycle that perpetuates disability.[@R28] A recent review of FoF[@R29] suggests that FoF contributes to falls risk on top of actual gait or balance problems. Exercise can reduce FoF,[@R30] at least in the short term, however FoF can also be a barrier to uptake of exercise programmes. Research suggests that perceived risk, stigma, lack of awareness among health professionals, lack of appropriate supporting materials and FoF may be barriers to exercise attendance.[@R7] [@R23] Enabling factors could include peer acceptability, appropriate supporting material with demonstration, sensitive explanation, carer involvement and individually tailored interventions.[@R7] [@R23]

The study draws on the learning from a number of previous studies, including the Falls Management Exercise (FaME)[@R31] programme, the visually impaired person (VIP) trial (prevention of falls in people aged ≥75 with severe visual impairment),[@R19] and the recently completed VIP2UK pilot study (Application Reference Number: UKCRN ID 10883) adapted from the Otago home-based programme to increase adherence in VIOP.[@R23] It is known that adherence to the Otago programme in VIOP was significantly lower than older people without significant visual impairment (only 18% VIOP completed all home exercise sessions over a year period[@R19]) and this may have been due to lack of confidence exercising at home without supervision. Although the VIP2UK study showed better compliance to exercise with additional support strategies (mentors, extra phone calls, audio exercise clips and embedding exercises into daily living) being in place but still low compared with previous studies of the Otago programme in general older adults.[@R23]

The FaME group-based programme was chosen as the preferred exercise intervention as a recent Royal College of Physicians report showed that 54% of falls services have trained postural stability instructors (PSIs) delivering the FaME programme in groups.[@R32] A 6-month programme of FaME exercises has also been shown to significantly increase habitual physical activity in older people recruited through primary care, by 15 min of moderate to vigorous activity a day even at 12 months postintervention, as well as reducing falls.[@R33]

This paper describes the protocol for the Visually Impaired OLder People\'s Exercise programme for falls prevenTion (VIOLET), feasibility study (V.1.1, 2 February 2015). The study was funded by the National Institute for Health Research (NIHR) Public Health Research (PHR) Programme.

The rationale for the study is to provide an opportunity for VIOP to contribute to the adaptation of a group-based falls prevention programme that is prevalent in falls services across the UK. This should facilitate an acceptable, feasible and appealing intervention that will improve uptake and adherence to a known effective intervention.

Aim of the study {#s2}
================

To conduct a mixed-methods feasibility and pilot study to inform the design and conduct of a future definitive multicentre randomised controlled trial (RCT) of an adapted group-based exercise programme to prevent falls and reduce FoF among VIOP.

Objectives {#s3}
==========

Feasibility study {#s3a}
-----------------

1.  Explore VIOP's ability to act as lay partners in a study to develop a condition-appropriate intervention.

2.  Explore VIOP's reasons for participating/not participating in the exercise programme and for those who participate, their experiences of the feasibility study procedures.

3.  Identify the feasibility, delivery and acceptability of candidate outcome measures for the future RCT (validated questionnaires/interview methods to measure FoF, activity avoidance, well-being/quality of life, anxiety, depression, loneliness and the number of falls) and VIOP centred/identified outcome measures.

4.  Explore the capacity to deliver the adapted exercise programme.

5.  Examine delivery (fidelity) and compliance of the exercise intervention.

Randomised control pilot {#s3b}
------------------------

1.  Assess recruitment of older people with visual impairment (VIOP) and their willingness to be randomised into the adapted falls prevention exercise programme.

2.  Test the methodology and to provide outcome data to inform sample size calculations for a definitive RCT.

3.  Assess the feasibility of collecting service-use data for an economic evaluation of the intervention in a future RCT.

4.  Develop a manualised intervention protocol and training package for a definitive RCT.

Study governance {#s4}
================

A Trial Management Group (TMG), including the chief investigator, study statistician, trial manager and database manager is responsible for overseeing the progress of this feasibility study. The day-to-day management is coordinated by Dr Rosy Lampitt, Trial Manager, Newcastle Clinical Trials Unit. A Trial Oversight Committee (TOC), with an independent Chair and including external members independent of the study, fulfils the combined role and responsibilities of a Data Monitoring and Ethics Committee (DMEC) and Trial Steering Committee (TSC). The TOC acts as the oversight body for this study on behalf of the sponsor and funder, safeguards the interests of study participants, assesses the safety and efficacy of the intervention, and monitors the overall conduct of the study. The TOC also protects the validity and credibility of the study, and provides advice through its independent Chair to the TMG, sponsor and funder on all aspects of the study.

Methods {#s5}
=======

Study design {#s5a}
------------

This is a two-centre randomised feasibility study of an adapted exercise programme for VIOP with embedded qualitative evaluation. The comparison is between a 12-week exercise programme (1-hour session per week plus two home-based sessions progressing from 30 min to 2 hours) and usual activities. Stakeholder panels of VIOP meeting at the two sites will discuss what adaptations to the FaME programme[@R31] are desirable and necessary to make the programme more accessible to VIOP.

Study setting, recruitment and screening {#s5b}
----------------------------------------

[Figure 1](#BMJOPEN2016011996F1){ref-type="fig"} provides a consort diagram of planned flow of participants for this study.

![Planned flow of participants throughout the VIOLET study. FaME, Falls Management Exercise; FES-I, Falls Efficacy Scale International; FRAT, Falls Risk Assessment Tool; GP, general practitioner; HADS, Hospital Anxiety and Depression Scale; TUG, Timed Up & Go test; VIOLET, Visually Impaired OLder people\'s Exercise programme for falls prevenTion; WSAS, Work and Social Adjustment Scale.](bmjopen2016011996f01){#BMJOPEN2016011996F1}

Eighty community-living VIOP aged 60 and over will be recruited (40 from each of the two study sites). In Newcastle, participants will be recruited from the Royal Victoria Infirmary\'s (RVI) Eye Centre and from Newcastle Society for the Blind\'s (NSBP) membership. In Glasgow, participants will be recruited from the Glasgow Caledonian University Low Vision Clinic and from the vision charity, Visibility Glasgow. Invitation letters and information about the study in large print or audio recorded (in the participant\'s preferred format) will be sent out through the Low Vision Units and the organisations for visually impaired people or handed out by the low vision specialist/activities coordinators. The participant information will be designed in consultation with the stakeholder panel and checked to ensure that it meets Royal National Institute for the Blind (RNIB) standards in terms of suitability for those with visual impairment.

VIOP who express interest in participating in the study will be screened for eligibility by a researcher over the telephone or on site, based on the inclusion/exclusion criteria below. Once informed consent has been gained, the participant\'s GP will be approached, via a letter explaining the inclusion and exclusion criteria, to make a judgement regarding the medical fitness of the participant to take part in the exercise intervention. A screening log will be completed by the research staff. It will document the outcome of the screening contact and record any reasons for screen failure. For participants who decline participation, the screening log will document any reasons available for non-participation. The log will also ensure potential participants are only approached once.

Inclusion criteria {#s5c}
------------------

Participants will be aged 60 years and over and attending a low vision clinic and/or are members of organisations for the visually impaired. They will also be living in their own home, able to walk indoors without the help of another person but may use a walking aid, such as a stick, able to walk outdoors but may need the help of another person and/or a walking aid and be physically able to take part in a group exercise class. The definition of visual impairment in the inclusion criteria is deliberately broad and pragmatic, in order to apply findings to the whole spectrum of older participants who may have vision difficulties and be at risk of falls. The extent to which participants perceive their visual impairment function and its impacts on daily living and any changes to their perceived visual function after the interventions will be gathered within interviews and will inform the methodology of the definitive trial.

Exclusion criteria {#s5d}
------------------

Those excluded will: (1) be unable to understand or follow simple movement instructions in English; (2) have acute or uncontrolled medical problems which the participant\'s GP considers would exclude them from undertaking the exercise programme (eg, uncontrolled heart disease, poorly controlled diabetes, acute systemic illness, neurological problems, severe chronic obstructive pulmonary disease), in addition to visual impairment; (3) have conditions requiring a specialist exercise programme, for example, uncontrolled epilepsy, severe neurological disease or impairment, unable to maintain a seated upright position or unable to move independently indoors; and (4) be currently involved in other falls prevention exercise programmes (but not excluding walking programmes), investigational studies or trials.

Consent procedures {#s5e}
------------------

Signed or recorded verbal consent to participate in the feasibility study (as appropriate for each VIOP participant) will be sought. If the VIOP is unable to sign the consent form, verbal consent will be witnessed by a third party, who will sign the witness section of the consent form. The participant will specifically consent to: (1) their GP being contacted regarding their medical fitness and being informed of their participation in the study; and (2) being informed that they will not be recruited if the GP considers the study to be a contraindication. The right to refuse to participate without giving reasons will be respected. It will also be explained that if it is felt the intervention is or has the potential to cause significant harm to a participant, then for safety reasons, the participant involvement will be discontinued. The information sheet and consent form for the study will be available only in English. It was decided to exclude participants who are unable to understand simple instructions in English, as they would not be able to understand the movement instructions given during the exercise sessions, if randomised to the intervention arm of the study.

Randomisation {#s5f}
-------------

A blocked allocation (permuted random blocks of variable length) system will be used to allocate participants to the two groups (block size will not be disclosed to the investigators) in a 1:1 ratio to intervention and control groups. Randomisation will be stratified by centre. Randomisation will be administered centrally via Newcastle Clinical Trials Unit using a secure web-based system. The principal investigator at site, or individual with delegate authority, will access the web-based system. Participant screening ID, initials and gender will be entered into the web-based system, which will return the allocation status. Participants will be informed by telephone, of their allocated treatment group following randomisation.

Study intervention {#s5g}
------------------

This two-centre randomised feasibility study incorporates a control and an intervention condition.

Control arm {#s5h}
-----------

Those participants who are randomised to the control group will receive no intervention but will be offered an opportunity to take part in an equivalent falls prevention exercise class, provided by local organisations currently delivering these classes after the follow-up period.

Intervention arm {#s5i}
----------------

For the intervention arm, local qualified PSIs working at each site will be trained by the research team members with PSI expertise (DAS and SG) on adapting the exercises for people with visual impairment, and following recommendations from the stakeholder panels. The PSIs will also receive visual impairment training from one of the partner organisations for people with visual impairment (Visibility).

The exercise class (the intervention) will run weekly over 12 weeks, with each session lasting up to 1 hour with an opportunity to socialise after the class. The exercises will consist of individually tailored and targeted training for dynamic balance, muscle and bone strength, endurance, flexibility, gait and functional skills, as well as training to improve 'righting' or 'correcting' skills to avoid a fall, backward chaining (getting down to and up from the floor safely) and functional floor exercises. A full description of the original exercise programming and progression has been published.[@R34]

If required, participants will be provided with transport (taxi) to and from the classes and can bring along someone for support or bring a guide dog. Participants will be also be advised to exercise at home for 30 min to 2 hours a week (using a progressive adapted standardised home exercise programme that has been used in other related studies[@R31] [@R33]). Exercises will be provided in a large print booklet, DVD or audio format and will consist of specific chair-based exercises to improve strength and flexibility and standing exercises to improve balance, power and bone health, already practiced within the class setting.

Data collection {#s5j}
---------------

Participants from the intervention and control groups will be telephoned each week by the study team for 24 weeks from baseline to record any adverse events, including falls that occur during the intervention period and for 12 weeks following the intervention. These will be assessed for duration, causality, expectedness, seriousness and severity as will any adverse events reported by the instructors within the exercise sessions. All non-serious adverse events (SAEs) will be reported on the study electronic case report form (eCRF) with hard copies sent to the Trial Management team within 4 weeks.

[Table 1](#BMJOPEN2016011996TB1){ref-type="table"} offers a participant schedule of events.

###### 

Violet study: participant schedule of events

                                                                   Baseline visit   Intervention or usual care/activities   Final follow-up                                                   
  -------------------------------------------------------- --- --- ---------------- --------------------------------------- ----------------- --- --- --- --- --- --- --- --- --- --- --- --- ---
  Identification: invitation letters/PIS sent/handed out   X                                                                                                                                  
  Screening                                                    X                                                                                                                              
  Informed consent                                                 X                                                                                                                          
  Letter sent to GP                                                                 X                                                                                                         
  Demographic data                                                                  X                                                                                                         
  Comorbidities                                                                     X                                                                                                     X   X
  Current medication                                                                X                                                                                                     X   X
  Socioeconomic information                                                         X                                                                                                     X   X
  FoF questionnaire                                                                 X                                                                                                     X   X
  Timed Up & Go test                                                                X                                                                                                     X   X
  Outcome questionnaires                                                            X                                                                                                     X   X
  QoL questionnaires                                                                X                                                                                                     X   X
  Randomisation                                                                                                             X                                                                  
  Falls diaries handed out                                                          X                                                                     X               X               X    
  Falls diaries collected                                                                                                                                 X               X               X   X
  Structured interviews with PSIs                                                                                           X                                                             X    
  Intervention: exercise sessions or usual activities                                                                                         X   X   X   X   X   X   X   X   X   X   X   X    
  Assessment of harms: phone calls                                                                                                            X   X   X   X   X   X   X   X   X   X   X   X   X
  In-depth qualitative interviews with OPVI                                                                                                                                               X    
  Review of attendance records                                                                                                                                                            X    

FoF, fear of falling; GP, general practitioner; OPVI, older person visually impaired; PSI, postural stability instructor; QoL, quality of life.

Data management and monitoring {#s5k}
------------------------------

Data will be entered on to a secure, password-protected, eCRF. As part of the data protection, confidentiality and anonymity requirements, all participants will be assigned a unique individual identifier. The database will be managed by the Clinical Trials Unit. Access will be limited to those deemed appropriate by the chief investigator. The research assistants, in conjunction with the database manager, and statisticians will carry out periodic data quality checks. These will include double data entry, snap shot analysis and query resolution. In relation to access to the final study data set, anonymised data will available from the chief investigator following an official request and ratification with the original members of the TOC, which was introduced in the 'Study governance' section above.

This is a low-risk trial and major safety data are not anticipated. The TOC will review any recorded SAEs (eg, injurious falls and/or hospitalisation due to falls) reported by the instructors within the exercise sessions or reported on the falls diaries returned by participants. The TOC will also monitor any trends in SAEs (eg, more than a few falls in the exercise groups during the exercise classes, or nearby, or a trend towards an increase in injury) and bring the intervention to a close, should this be deemed necessary. Overall the sponsor is responsible for auditing study conduct.

Outcome measures {#s5l}
----------------

Standardised assessment instruments that have been used in falls research and with older people will be administered and are listed in [box 1](#bx1){ref-type="boxed-text"}.[@R35] The primary outcomes are related to feasibility, including the number of participants that are recruited (recruitment), that provide data at 24-week follow-up (retention), and attend a substantial amount (9/12) of the group exercise sessions if allocated to the intervention arm (adherence). Data will be collected at baseline, 12 and 24 weeks ([box 1](#bx1){ref-type="boxed-text"}). The primary outcome of the future definitive RCT will be decided by the responsiveness to change, participant burden and participant feedback from this study. Box 1Outcome assessment toolsFear of falling (Short Falls Efficacy Scale---International (FES-I)[@R35]);Activity avoidance (2 questions[@R36]);Balance/falls risk (Timed Up & Go test (TUG)[@R37]);Falls Risk Assessment Tool (FRAT[@R38]);Number of falls (falls diary and weekly telephone call[@R39]);Self-reported physical activity (Phone-FITT[@R40]);Loneliness (6-Item Scale for Overall Emotional and Social Loneliness[@R41]);Anxiety and depression (Hospital Anxiety and Depression Scale (14 items)[@R42]);Work and Social Adjustment Scale (WSAS[@R43]);Quality of life (EQ-5D-5L[@R44] and ICEpop CAPability measure for Older people (ICECAP-O)[@R45]);Resource use via a health economic self-report service receipt inventory;Adherence to the group exercise programme (register) and home exercise programme (self-reported).

FoF is likely to be selected as the primary outcome measure because while FoF is a common, debilitating and a significant predictor of a future fall particularly among older people,[@R46] successful management of FoF is limited and unknown in VIOP. Recent reviews[@R26] [@R28] [@R30] [@R47] show that there is a lack of high-quality research, which has FoF as a primary health outcome, provides guidance on routine practice in this area and translates research of FoF interventions to clinical settings. In addition, there is limited health economic data about FoF interventions.[@R28] [@R29] Measuring the number of falls as a primary outcome does not take into account the more complex impacts of an intervention, which by reducing FoF, may increase participants\' confidence in their ability to walk safely and continue to enjoy everyday activities. Assessing FoF before and after the proposed intervention captures participants\' perceptions of change in their confidence to continue with physical and social activities. This in turn gives an indication of their perceived quality of life and whether the negative impacts of FoF, such as social isolation and risk of further falls, have been reduced.

Qualitative evaluation of the feasibility study {#s6}
===============================================

Interviews with VIOP {#s6a}
--------------------

In-depth qualitative interviews will be conducted with a purposive sample of VIOP (∼3--5 from each site) to explore reasons for taking part; factors that facilitate/hinder them from participating in community-based falls prevention exercise groups; and experiences of recruitment and randomisation; views on outcome measures; experiences of the adapted intervention. The interviews with VIOP who complete the 12-week exercise programme (the intervention) will be conducted within 2 weeks following the end of trial data collection. Any VIOP who drops out during the intervention will also be contacted within 2 weeks of dropping out and asked if they would be willing to be interviewed by the researcher about their experiences of the intervention and the research and their reasons for dropping out.

The interviews will be conducted by the researchers in the form of a brief telephone conversation with a set of standardised questions, followed by, if willing, a face-to-face interview in a safe location chosen by the interviewee, such as their own home.

Interviews with postural stability instructors {#s6b}
----------------------------------------------

Structured interviews will be conducted with the PSIs. They will be interviewed at two points (before training and at the end of the intervention) to explore their (changing) perspectives on the provision of the intervention to VIOP over the duration of the intervention.

Economic evaluation {#s7}
===================

A prospective economic evaluation will be rehearsed to develop and refine methods for a subsequent definitive trial. The main focus will be on how to accurately identify, quantify and value the additional costs of delivering the intervention and the potential resource implications versus usual 'activity' and on what measurement tools are appropriate to use with VIOP. The costing approach will incorporate a broad analytical perspective (NHS, social services and patient/carer costs), which will help to detect cost-shifting between sectors. Resources used in the exercise group will be identified in terms of capital equipment, staff time and travel/time for patients. Resource use in terms of out of pocket expenses will also be explored for all participants in addition to all treatment/care related to the intervention and any falls that may occur during the study period. This will be assessed retrospectively at the two follow-up periods (12 weeks and 6 months) by piloting the use of a falls resources/expenses form (to include informal caregivers time). This will facilitate the development of a reliable and valid tool to capture resource use. Appropriate unit costs to be applied to resource use will be identified. These will be sourced from a combination of local costings and national databases. Methods to value informal carer time will also be explored and defined, and all costs will be combined to rehearse the methods for total health, social care and patient/carer cost estimation in a subsequent definitive trial.

Data analysis {#s8}
=============

As this is a feasibility study, a formal power calculation is not appropriate. We would aim to obtain a minimum of 30 responses in each trial arm at 6-month follow-up to estimate the critical parameters to the necessary degree of precision.[@R48] To provide feasibility data, a total of 80 community-living VIOP aged 60+ will be recruited from NHS Low Vision Units and voluntary organisations to allow for loss to follow-up. As recruitment and retention rates are a relative unknown in this population, we will seek advice from the stakeholder groups on how best to reach them.

The main analyses will be descriptive, in order to inform the design of a future definitive study. We will calculate the numbers of eligible participants seen over the recruitment period, and the resulting rates of recruitment, compliance with randomisation, and data completion. We will also ascertain data completeness of the instruments and any potential bias in the completion of follow-up data to inform the choice of instruments in a future trial. The majority of the outcome data will be presented in simple descriptive tables presenting percentages, means and SDs or five-number summary (as appropriate), for each arm of the study. This information will be used to inform the design, choice of primary outcome, necessary sample size and approach to the analysis of the future definitive trial.

There is a potential for clustering effects, particularly class-based clustering in the intervention group and it will be part of the function of the pilot trial to investigate and estimate the size of any such effects. As this is a feasibility study, the results will provide estimates of variability in key outcomes both within and between classes and trial arms, which will be used to design a future definitive trial. However, there will be very limited information on the size of intraclass correlation coefficient (ICC) in a study with only two centres and two classes per centre, and any estimates of ICC based on this pilot trial will be very imprecise.

Qualitative analysis {#s9}
====================

The interviews will be audio-taped and transcribed. Framework analysis will be used to analyse the interviews with the VIOP and PSIs.[@R49] This has four non-linear interconnected stages: familiarisation of data, identifying a thematic framework, indexing data into the framework, developing charts from categories that are identified within the framework and finally mapping and interpretation. This will first be carried out within each site independent of the other and then combined with iterations until consensus is reached. The main themes and categories of the analysis will be shared with participants for member checking.

Criteria for success {#s10}
====================

Following analysis of the qualitative interviews, the investigators will document the practicality of the study design, its impact on and acceptability to, both older people with visual impairment and professionals, and the acceptability and applicability of the outcome measures for older person visually impaired (OPVI). The conclusions from this discussion will inform the development of a definitive RCT and an intervention manual.

The progression criteria to judge the feasibility of progressing to a full trial will be based on: ≥50% of OPVI eligible for the study willing to be recruited into the feasibility study;≥70% of the participants in the intervention arm complete 9/12 group sessions in the exercise programme (compliance);Data collected on key outcomes at 6-month follow-up for ≥70% of those recruited;\<10% of SAEs deemed due to the intervention itself.

Ethical approval {#s11}
================

Glasgow Caledonian University was approved as a non-NHS site with local ethics approval. In addition, ethical approval was sought from the sponsoring institution: Northumbria University, and where needed the Research and Development department of the NHS Trust. As part of the ethical approval process, assurances were given regarding the processes in place to assure confidentiality and anonymity. Personal data will be regarded as strictly confidential. To preserve anonymity, any data leaving the site will identify participants using their unique study identification code only. The study will comply with the Data Protection Act, 1998. All study records and investigator site files will be kept at site in a locked filing cabinet with restricted access. No amendment to the protocol will be made without consideration and approval by the Trial Management Committee. Authorisation for any approval will be sought from the National Research Ethics Service (NRES) and NIHR. Reports regarding the progress of the study will be submitted as required to NRES and National Institute for Health Research (NIHR).

Dissemination strategy {#s12}
======================

Results will be published in an open access peer-reviewed journal. The preliminary results from this feasibility study will be shared and discussed with the original stakeholder panel and the two charities involved. They will shape the dissemination strategy but this is likely to include articles and news items for vision charities and older people organisations, falls services, and disability and health policymakers.

Discussion {#s13}
==========

The VIOLET study is designed to investigate the feasibility of a future definitive trial of the FaME exercise programme adapted for VIOP. There are potential risks and benefits to introducing exercises to this population. FoF in VIOP may exacerbate existing gait and balance difficulties, further increasing the risk of falls. Recent research has shown that older people are at increased risk of falling following intensive endurance exercise bouts,[@R50] through exercise-induced alterations in respiration and muscular fatigue. It was noted that visual impairment could increase exercise-induced changes to postural control, and consequently the risk of falling.

This study will enable VIOP to collaborate with researchers and instructors to draw on their expertise and experience to adapt a commonly adopted exercise programme, that is known to reduce falls risk in high-risk frequent fallers[@R31] and low-risk older adults,[@R33] to their specific VI needs. This in turn may have positive impacts on gait and balance, increase confidence and lessen FoF. This study will add to an emerging body of work that is using FoF, as assessed by a widely validated cross-cultural tool (Falls Efficacy Scale International, FES-I), to address the gap in knowledge of how to manage FoF successfully.

The feasibility study will develop a manualised intervention, identify potential barriers and facilitating factors to recruitment and retention, and test aspects of the trial methodology to inform the design of a future definitive trial of an adapted exercise programme for VIOP.
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